Pancreatic Cancer: Current Situation and Challenges

VIEWS - 131 (Abstract) 58 (PDF)
Cheng Jin, Ling Bai

Abstract


none

Full Text:

Download PDF

References


Rahib L, Smith BD, Aizenberg R, et al., 2014, Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States. Cancer Res, 74(11):2913–21. DOI: 1158/0008-5472.can-14-0155.

Rawla P, Sunkara T, Gaduputi V, 2019, Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol, 10(1):10–27. DOI: 10.14740/ wjon1166.

Canto MI, Hruban RH, Fishman EK, et al., 2012, Frequent Detection of Pancreatic Lesions in Asymptomatic High-risk Individuals. Gastroenterology, 142(4):796–804.

Varadarajulu S, Wallace MB, 2004, Applications of Endoscopic Ultrasonography in Pancreatic Cancer. Cancer Control, 11(1):15–22. DOI: 10.1177/107327480401100203.

Drouillard A, Manfredi S, Lepage C, et al., 2018, Epidemiology of Pancreatic Cancer. Bull Cancer, 105(1):63–9.

Wolfgang CL, Herman JM, Laheru DA, et al., 2013, Recent Progress in Pancreatic Cancer. CA Cancer J Clin, 63(5):318–48.

Ilic M, Ilic I, 2016, Epidemiology of Pancreatic Cancer. World J Gastroenterol, 22(44):9694–705. DOI: 10.3748/ wjg.v22.i44.9694.

Javle M, Li Y, Tan D, et al., 2014, Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer. PLoS One, 9(1):e85942. DOI: 10.1371/journal. pone.0085942.

Naito S, Bilim V, Yuuki K, et al., 2010, Glycogen Synthase Kinase-3beta: A Prognostic Marker and a Potential Therapeutic Target in Human Bladder Cancer. Clin Cancer Res, 16(21):5124–32. DOI: 10.1158/1078-0432.ccr-10-0275.

Hwang TL, Liang Y, Chien KY, et al., 2006, Overexpression and Elevated Serum Levels of Phosphoglycerate Kinase 1 in Pancreatic Ductal Adenocarcinoma. Proteomics, 6(7):2259–72. DOI: 10.1002/pmic.200500345.

Ning Z, Wang A, Liang J, et al., 2014, USP22 Promotes the G1/S Phase Transition by Upregulating FoxM1 Expression Via β-catenin Nuclear Localization and is Associated with Poor Prognosis in Stage II Pancreatic Ductal Adenocarcinoma. Int J Oncol, 45(4):1594–608. DOI: 10.3892/ijo.2014.2531.

Knudsen ES, O’Reilly EM, Brody JR, et al., 2016, Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine. Gastroenterology, 150(1):48–63. DOI: 10.1053/j.gastro.2015.08.056.

Liu M, Ji S, Xu X, et al., 2020. Advances in Basic Research, Clinical Diagnosis and Treatment of Pancreatic Cancer in 2019. China Oncol, 30(1):1–10.




DOI: http://dx.doi.org/10.18063/ghl.v2i1.243

Refbacks

  • There are currently no refbacks.


Copyright (c) 2020 Jin and Bai.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Recent Articles | About Journal | For Author | Fees | About Whioce

Copyright © Whioce Publishing Pte Ltd. All Rights Reserved.